Brain to blood glutamate scavenging as a novel therapeutic modality: A review

Journal of Neural Transmission

Volumn 121, Issue 8, 2014, Pages 971-979

  Boyko, Matthew ^a   Gruenbaum, Shaun E ^b   Gruenbaum, Benjamin F ^b   Shapira, Yoram ^a   Zlotnik, Alexander ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood glutamate scavenging; Neuroprotection

Indexed keywords

ESTROGEN; GLUCAGON; GLUTAMIC ACID; INSULIN; OXALOACETIC ACID; PROGESTERONE; PYRUVIC ACID; NEUROPROTECTIVE AGENT;

ARTICLE; BLOOD BRAIN BARRIER; CEREBROVASCULAR ACCIDENT; CIRCADIAN RHYTHM; EPILEPSY; EVOKED RESPONSE; EXTRACELLULAR FLUID; GLIOMA; HEMODIALYSIS; HOMEOSTASIS; HUMAN; HYPERTHERMIA; HYPOTHERMIA; LATERAL BRAIN VENTRICLE; MIGRAINE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGANOPHOSPHATE POISONING; PERITONEAL DIALYSIS; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN INJURY; ANIMAL; BLOOD; BRAIN; BRAIN DISEASES; DRUG EFFECTS; METABOLISM;

ANIMALS; BRAIN; BRAIN DISEASES; GLUTAMIC ACID; HUMANS; NEUROPROTECTIVE AGENTS;

EID: 84925711068     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-014-1181-7     Document Type: Article

References (89)

1. Arun P, Abu-Taleb R, Oguntayo S et al (2013) Acute mitochondrial dysfunction after blast exposure: potential role of mitochondrial glutamate oxaloacetate transaminase. J Neurotrauma
2. Baker AJ, Moulton RJ, MacMillan VH, Shedden PM (1993) Excitatory amino acids in cerebrospinal fluid following traumatic brain injury in humans. J Neurosurg 79:369-372
3. Behl C (2002) Oestrogen as a neuroprotective hormone. Nat Rev Neurosci 3:433-442
4. Berger C, Schabitz WR, Georgiadis D, Steiner T, Aschoff A, Schwab S (2002) Effects of hypothermia on excitatory amino acids and metabolism in stroke patients: a microdialysis study. Stroke 33:519-524
5. Berger C, Schabitz WR, Wolf M, Mueller H, Sommer C, Schwab S (2004) Hypothermia and brain-derived neurotrophic factor reduce glutamate synergistically in acute stroke. Exp Neurol 185:305-312
6. Boyko M, Zlotnik A, Gruenbaum BF et al (2011) Pyruvate's blood glutamate scavenging activity contributes to the spectrum of its neuroprotective mechanisms in a rat model of stroke. Eur J Neurosci 34:1432-1441
7. Boyko M, Melamed I, Gruenbaum BF et al (2012a) The effect of blood glutamate scavengers oxaloacetate and pyruvate on neurological outcome in a rat model of subarachnoid hemorrhage. Neurotherapeutics 9:649-657
8. Boyko M, Stepensky D, Gruenbaum BF et al (2012b) Pharmacokinetics of glutamate-oxaloacetate transaminase and glutamatepyruvate transaminase and their blood glutamate-lowering activity in naive rats. Neurochem Res 37:2198-2205
9. Boyko M, Kuts R, Gruenbaum BF et al (2013) The role of hypothermia in the regulation of blood glutamate levels in naive rats. J Neurosurg Anesthesiol 25:174-183
10. Bullock R, Zauner A, Woodward JJ et al (1998) Factors affecting excitatory amino acid release following severe human head injury. J Neurosurg 89:507-518
11. Campos F, Rodriguez-Yanez M, Castellanos M et al (2011a) Blood levels of glutamate oxaloacetate transaminase are more strongly associated with good outcome in acute ischaemic stroke than glutamate pyruvate transaminase levels. Clin Sci (Lond) 121:11-17
12. Campos F, Sobrino T, Ramos-Cabrer P et al (2011b) High blood glutamate oxaloacetate transaminase levels are associated with good functional outcome in acute ischemic stroke. J Cereb Blood Flow Metab 31:1387-1393
13. Campos F, Sobrino T, Ramos-Cabrer P et al (2011c) Neuroprotection by glutamate oxaloacetate transaminase in ischemic stroke: an experimental study. J Cereb Blood Flow Metab 31:1378-1386
14. Campos F, Sobrino T, Ramos-Cabrer P, Castillo J (2012a) Oxaloacetate: a novel neuroprotective for acute ischemic stroke. Int J Biochem Cell Biol 44:262-265
15. Campos F, Perez-Mato M, Agulla J et al (2012b) Glutamate excitotoxicity is the key molecular mechanism which is influenced by body temperature during the acute phase of brain stroke. PLoS One 7:e44191
16. Campos F, Sobrino T, Perez-Mato M et al (2013) Glutamate oxaloacetate transaminase: a new key in the dysregulation of glutamate in migraine patients. Cephalalgia
17. Carvalho AS, Torres LB, Persike DS et al (2011) Neuroprotective effect of pyruvate and oxaloacetate during pilocarpine induced status epilepticus in rats. Neurochem Int 58:385-390
18. Castellanos M, Sobrino T, Pedraza S et al (2008) High plasma glutamate concentrations are associated with infarct growth in acute ischemic stroke. Neurology 71:1862-1868
19. Castillo J, Davalos A, Naveiro J, Noya M (1996) Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke. Stroke 27:1060-1065
20. Castillo J, Davalos A, Noya M (1997) Progression of ischaemic stroke and excitotoxic aminoacids. Lancet 349:79-83
21. Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65:1-105
22. de Groot J, Sontheimer H (2011) Glutamate and the biology of gliomas. Glia 59:1181-1189
23. Dubal DB, Kashon ML, Pettigrew LC et al (1998) Estradiol protects against ischemic injury. J Cereb Blood Flow Metab 18:1253-1258
24. Dubal DB, Shughrue PJ, Wilson ME, Merchenthaler I, Wise PM (1999) Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors. J Neurosci 19:6385-6393
25. Eid T, Williamson A, Lee TS, Petroff OA, de Lanerolle NC (2008a) Glutamate and astrocytes-key players in human mesial temporal lobe epilepsy? Epilepsia 49(Suppl 2):42-52
26. Eid T, Ghosh A, Wang Y et al (2008b) Recurrent seizures and brain pathology after inhibition of glutamine synthetase in the hippocampus in rats. Brain 131:2061-2070
27. Fanne RA, Nassar T, Mazuz A et al (2011a) Neuroprotection by glucagon: role of gluconeogenesis. J Neurosurg 114:85-91
28. Fanne RA, Nassar T, Heyman SN, Hijazi N, Higazi AA (2011b) Insulin and glucagon share the same mechanism of neuroprotection in diabetic rats: role of glutamate. Am J Physiol Regul Integr Comp Physiol 301:R668-R673
29. Ferrarese C, Aliprandi A, Tremolizzo L et al (2001) Increased glutamate in CSF and plasma of patients with HIV dementia. Neurology 57:671-675
30. Ferrari A, Spaccapelo L, Pinetti D, Tacchi R, Bertolini A (2009) Effective prophylactic treatments of migraine lower plasma glutamate levels. Cephalalgia 29:423-429
31. GodinoMdel C, Romera VG, Sanchez-Tomero JA et al (2013) Amelioration of ischemic brain damage by peritoneal dialysis. J Clin Investig 123:4359-4363
32. Gottlieb M, Wang Y, Teichberg VI (2003) Blood-mediated scavenging of cerebrospinal fluid glutamate. J Neurochem 87:119-126
33. Hosoya K, Sugawara M, Asaba H, Terasaki T (1999) Blood-brain barrier produces significant efflux of L-aspartic acid but not Daspartic acid: in vivo evidence using the brain efflux index method. J Neurochem 73:1206-1211
34. Ikonomidou C, Turski L (2002) Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol 1:383-386
35. Johnston MV, Trescher WH, Ishida A, Nakajima W (2001) Neurobiology of hypoxic-ischemic injury in the developing brain. Pediatr Res 49:735-741
36. Lau A, Tymianski M (2010) Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch 460:525-542
37. Lee JM, Zipfel GJ, Choi DW (1999) The changing landscape of ischaemic brain injury mechanisms. Nature 399:A7-A14
38. Lee TS, Mane S, Eid T et al (2007) Gene expression in temporal lobe epilepsy is consistent with increased release of glutamate by astrocytes. Mol Med 13:1-13
39. Leibowitz A, Boyko M, Shapira Y, Zlotnik A (2012) Blood glutamate scavenging: insight into neuroprotection. Int J Mol Sci 13:10041-10066
40. Lipton P (1999) Ischemic cell death in brain neurons. Physiol Rev 79:1431-1568
41. Mangia S, Giove F, Dinuzzo M (2012) Metabolic pathways and activity-dependent modulation of glutamate concentration in the human brain. Neurochem Res 37:2554-2561
42. Marliss EB, Aoki TT, Pozefsky T, Most AS, Cahill GF Jr (1971) Muscle and splanchnic glutamine and glutamate metabolism in postabsorptive and starved man. J Clin Investig 50:814-817
43. Marosi M, Fuzik J, Nagy D et al (2009) Oxaloacetate restores the long-term potentiation impaired in rat hippocampus CA1 region by 2-vessel occlusion. Eur J Pharmacol 604:51-57
44. McCulloch J (1992) Excitatory amino acid antagonists and their potential for the treatment of ischaemic brain damage in man. Br J Clin Pharmacol 34:106-114
45. Muir KW (2006) Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists. Curr Opin Pharmacol 6:53-60
46. Nagy D, Marosi M, Kis Z et al (2009) Oxaloacetate decreases the infarct size and attenuates the reduction in evoked responses after photothrombotic focal ischemia in the rat cortex. Cell Mol Neurobiol 29:827-835
47. O'Kane RL, Martinez-Lopez I, DeJoseph MR, Vina JR, Hawkins RA (1999) Na(?)-dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) of the blood-brain barrier. A mechanism for glutamate removal. J Biol Chem 274:31891-31895
48. Palmer AM, Marion DW, Botscheller ML, Swedlow PE, Styren SD, DeKosky ST (1993) Traumatic brain injury-induced excitotoxicity assessed in a controlled cortical impact model. J Neurochem 61:2015-2024
49. Ramadan NM (2003) The link between glutamate and migraine. CNS Spectr 8:446-449
50. Richards DA, Tolias CM, Sgouros S, Bowery NG (2003) Extracellular glutamine to glutamate ratio may predict outcome in the injured brain: a clinical microdialysis study in children. Pharmacol Res 48:101-109
51. Rodriguez-Rodriguez P, Almeida A, Bolanos JP (2013) Brain energy metabolism in glutamate-receptor activation and excitotoxicity: role for APC/C-Cdh1 in the balance glycolysis/pentose phosphate pathway. Neurochem Int 62:750-756
52. Rogachev B, Ohayon S, Saad A et al (2012) The effects of hemodialysis on blood glutamate levels in chronic renal failure: implementation for neuroprotection. J Crit Care 27(743):e1-e7
53. Rogachev B, Tsesis S, Gruenbaum BF et al (2013) The effects of peritoneal dialysis on blood glutamate levels: implementation for neuroprotection. J Neurosurg Anesthesiol 25:262-266
54. Rose ME, Huerbin MB, Melick J et al (2002) Regulation of interstitial excitatory amino acid concentrations after cortical contusion injury. Brain Res 943:15-22
55. Ruban A, Berkutzki T, Cooper I, Mohar B, Teichberg VI (2012) Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas. Invest New Drugs 30:2226-2235
56. Ruban A, Mohar B, Jona G, Teichberg VI (2013) Blood glutamate scavenging as a novel neuroprotective treatment for paraoxon intoxication. J Cereb Blood Flow Metab
57. Schousboe A (1981) Transport and metabolism of glutamate and GABA in neurons are glial cells. Int Rev Neurobiol 22:1-45
58. Shaw PJ, Forrest V, Ince PG, Richardson JP, Wastell HJ (1995) CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients. Neurodegeneration 4:209-216
59. Slooter AJ, Bronzova J, Witteman JC, Van Broeckhoven C, Hofman A, van Duijn CM (1999) Estrogen use and early onset Alzheimer's disease: a population-based study. J Neurol Neurosurg Psychiatry 67:779-781
60. Sontheimer H (2003) Malignant gliomas: perverting glutamate and ion homeostasis for selective advantage. Trends Neurosci 26:543-549
61. Sontheimer H (2004) Ion channels and amino acid transporters support the growth and invasion of primary brain tumors. Mol Neurobiol 29:61-71
62. Spranger M, Krempien S, Schwab S, Maiwald M, Bruno K, Hacke W (1996) Excess glutamate in the cerebrospinal fluid in bacterial meningitis. J Neurol Sci 143:126-131
63. Stegink LD, Filer LJ Jr, Baker GL (1983) Plasma amino acid concentrations in normal adults fed meals with added monosodium L-glutamate and aspartame. J Nutr 113:1851-1860
64. Stegink LD, Filer LJ Jr, Baker GL (1985) Plasma glutamate concentrations in adult subjects ingesting monosodium L-glutamate in consomme. Am J Clin Nutr 42:220-225
65. Tang MX, Jacobs D, Stern Y et al (1996) Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348:429-432
66. Teichberg VI (2011) GOT to rid the body of excess glutamate. J Cereb Blood Flow Metab 31:1376-1377
67. Teichberg VI, Cohen-Kashi-Malina K, Cooper I, Zlotnik A (2009) Homeostasis of glutamate in brain fluids: an accelerated brainto- blood efflux of excess glutamate is produced by blood glutamate scavenging and offers protection from neuropathologies. Neuroscience 158:301-308
68. Tsai PJ, Huang PC (2000) Circadian variations in plasma and erythrocyte glutamate concentrations in adult men consuming a diet with and without added monosodium glutamate. J Nutr 130:1002S-1004S
69. Tsesis S, Gruenbaum BF, Ohayon S et al (2013) The effects of estrogen and progesterone on blood glutamate levels during normal pregnancy in women. Gynecol Endocrinol
70. Veliskova J, Velisek L, Galanopoulou AS, Sperber EF (2000) Neuroprotective effects of estrogens on hippocampal cells in adult female rats after status epilepticus. Epilepsia 41(Suppl 6):S30-S35
71. Wang Q, Santizo R, Baughman VL, Pelligrino DA, Iadecola C (1999) Estrogen provides neuroprotection in transient forebrain ischemia through perfusion-independent mechanisms in rats. Stroke 30:630-637
72. Yang SH, Shi J, Day AL, Simpkins JW (2000) Estradiol exerts neuroprotective effects when administered after ischemic insult. Stroke 31:745-749 discussion 9-50
73. Ye ZC, Sontheimer H (1999) Glioma cells release excitotoxic concentrations of glutamate. Cancer Res 59:4383-4391
74. Yudkoff M, Daikhin Y, Nissim I, Lazarow A, Nissim I (2004) Ketogenic diet, brain glutamate metabolism and seizure control. Prostaglandins Leukot Essent Fatty Acids 70:277-285
75. Yudkoff M, Daikhin Y, Melo TM, Nissim I, Sonnewald U, Nissim I (2007) The ketogenic diet and brain metabolism of amino acids: relationship to the anticonvulsant effect. Annu Rev Nutr 27:415-430
76. Zauner A, Bullock R, Kuta AJ, Woodward J, Young HF (1996) Glutamate release and cerebral blood flow after severe human head injury. Acta Neurochir Suppl 67:40-44
77. Zlotnik A, Gurevich B, Tkachov S, Maoz I, Shapira Y, Teichberg VI (2007) Brain neuroprotection by scavenging blood glutamate. Exp Neurol 203:213-220
78. Zlotnik A, Gurevich B, Cherniavsky E et al (2008) The contribution of the blood glutamate scavenging activity of pyruvate to its neuroprotective properties in a rat model of closed head injury. Neurochem Res 33:1044-1050
79. Zlotnik A, Gruenbaum SE, Artru AA et al (2009) The neuroprotective effects of oxaloacetate in closed head injury in rats is mediated by its blood glutamate scavenging activity: evidence from the use of maleate. J Neurosurg Anesthesiol 21:235-241
80. Zlotnik A, Klin Y, Kotz R et al (2010a) Regulation of blood Lglutamate levels by stress as a possible brain defense mechanism. Exp Neurol 224:465-471
81. Zlotnik A, Gurevich B, Artru AA et al (2010b) The effect of hyperthermia on blood glutamate levels. Anesth Analg 111:1497-1504
82. Zlotnik A, Ohayon S, Gruenbaum BF et al (2011a) Determination of factors affecting glutamate concentrations in the whole blood of healthy human volunteers. J Neurosurg Anesthesiol 23:45-49
83. Zlotnik A, Gruenbaum BF, Mohar B et al (2011b) The effects of estrogen and progesterone on blood glutamate levels: evidence from changes of blood glutamate levels during the menstrual cycle in women. Biol Reprod 84:581-586
84. Zlotnik A, Klin Y, Gruenbaum BF et al (2011c) The activation of beta2-adrenergic receptors in naive rats causes a reduction of blood glutamate levels: relevance to stress and neuroprotection. Neurochem Res 36:732-738
85. Zlotnik A, Gruenbaum BF, Klin Y et al (2011d) The effects of insulin, glucagon, glutamate, and glucose infusion on blood glutamate and plasma glucose levels in naive rats. J Neurosurg Anesthesiol 23:323-328
86. Zlotnik A, Tsesis S, Gruenbaum BF et al (2012a) Relationship between glutamate, GOT and GPT levels in maternal and fetal blood: a potential mechanism for fetal neuroprotection. Early Hum Dev 88:773-778
87. Zlotnik A, Sinelnikov I, Gruenbaum BF et al (2012b) Effect of glutamate and blood glutamate scavengers oxaloacetate and pyruvate on neurological outcome and pathohistology of the hippocampus after traumatic brain injury in rats. Anesthesiology 116:73-83
88. Zlotnik A, Leibowitz A, Gurevich B et al (2012c) Effect of estrogens on blood glutamate levels in relation to neurological outcome after TBI in male rats. Intensive Care Med 38:137-144
89. Zlotnik A, Klin Y, Gruenbaum BF et al (2012d) Beta2 adrenergicmediated reduction of blood glutamate levels and improved neurological outcome after traumatic brain injury in rats. J Neurosurg Anesthesiol 24:30-38